United Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.93 million in common shares - UTHR News | RalliesUnited Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.93 million in common shares
U
UTHR• Insider share activity disclosed in SEC filing
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on July 23, 2026.
- A family trust sold 11,500 shares the same day at weighted-average prices ranging from USD 522.87 to USD 531.83.
- The trust’s common-stock stake fell to 324,443 shares following the sales.
- The filing also showed 40,513 shares held directly.
